Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
for Chronic Lymphocytic Leukemia (CLL)
Drug: Venetoclax
8 locations incl. Evanston
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT03824483·Phase 2·Recruiting